Articles By Rob Wright, Chief Editor
From Food To Pharma — Andrea Pfeifer’s Trek To Cure Alzheimer’s
CEO Andrea Pfeifer talks about why, years ago, she was convinced it was time to leave her career in the food industry and cofound AC Immune, a biopharma focused on one of the most difficult areas — Alzheimer’s disease.
It’s Time We Ready Americans For The COVID-19 Long Haul
Rob Wright issues a call to action to everyone connected to the biopharmaceutical industry, recommending they begin communicating the realities of developing and distributing a COVID-19 vaccine by the end of this year.
A Small Biopharma’s View Of Working With CROs
Running a clinical-stage oncology biopharma with only five employees means you quickly learn a thing or two about the value of outsourcing services. For Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, those learnings have led to her company using five CROs for the company’s lead investigational candidate.
Aligos Therapeutics — The Next Step Of Lawrence Blatt’s Entrepreneurial Expedition
Lawrence Blatt, Ph.D., cofounder and CEO of Aligos Therapeutics, discusses the entrepreneurial journey that took him from startup, to Big Pharma, back to startup.
Building A Digital Therapeutics Company
Brent Vaughan talks about the differences between building a biotech and building a digital therapeutics company.
What’s With All The Stuff On Corporate Culture?
If you found a moment of tranquility during the lockdown of this pandemic, then you may have started to reflect on what’s really important — at home and the office. I recently found myself pondering the concept of corporate culture.
Readying For A Virtual Fireside Chat With A Biomanufacturing Icon
Biomanufacturing icon Andy Skibo, and Life Science Leader chief editor Rob Wright, on topics and planning for upcoming fireside chat at the American Biomanufacturing Summit 2020 that has now gone virtual.
BIO Digital Makes The Best Of A Bad COVID-19 Situation
Life Science Leader’s Rob Wright provides perspective on BIO Digital 2020, and a recommendation for the session every BIO Digital registered attendee should make time to attend.
A Chat On Biosimilars With Sandoz’s U.S. President Carol Lynch
Carol Lynch, president of Sandoz U.S. and head of North America, fields biosimilars-related questions from the audience at the 2020 BIO CEO & Investor Conference.